|Hormonal treatment aims mostly at improving levels of endogenous follicle stirring hormone and/or androgen and subsequent spermatogenesis. Treatment with gonadotrophins such as Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) may be active in patients with hypogonadotrophic hypogonadism. As an example, Tamoxifen citrate is an anti-estrogenic agent, used as a single prophylactic agent in hormone responsive breast cancer. This drug is to recover sperm quality in patients with asthenozoospermia.
The open access journals are peer reviewed scholarly journals of Andrology Open Access. The top open access journals are freely available on the public internet domain, allowing any end users to read, download, copy, distribute, prink, search or link to the full texts of the articles. These provide high quality, meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These journals are indexed with all their citations noted. The top open access journals are indexed in SCOPUS, COPERNICUS, CAS, EBSCO and ISI.